Screening Patients With Central Nervous System Tumors for Participation in National Cancer Institute Clinical Trials
| Status: | Archived |
|---|---|
| Conditions: | Brain Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
Eligibility Screening Of Patients With Central Nervous System Tumors For The National Cancer Institute's (NCI) Clinical Research Protocols
RATIONALE: Screening tests may help doctors determine which patients are eligible for
treatment on clinical trials.
PURPOSE: This clinical trial is screening patients with central nervous system tumors for
participation in National Cancer Institute (NCI) clinical trials.
OBJECTIVES:
- Evaluate patients with central nervous system tumors for eligibility in NCI primary
clinical research protocols.
OUTLINE: Patients undergo various diagnostic procedures and clinical testing to determine
eligibility for participation in NCI CNS tumor primary clinical research protocols. Patients
undergo imaging scans; laboratory testing of blood, cerebrospinal fluid, bone marrow, urine,
and other specimens as needed to determine protocol eligibility; and other specific organ
function tests.
PROJECTED ACCRUAL: A maximum of 3,000 patients will be accrued for this study within 5
years.
We found this trial at
1
site
National Cancer Institute (NCI) The National Cancer Institute (NCI) is part of the National Institutes...
Click here to add this to my saved trials
